Systematic review links chronic post-cesarean pain to sustained functional impairment in 15-17% of mothers

{"The review aggregated observational cohorts and cross-sectional data across 22 countries, showing 43-55% of affected women reported pain-related interference with walking, work and sleep in the first three months; mood interference rose to 69% by 12 months. One large cohort documented fivefold higher odds of depressive symptoms at three and six months. These patterns align with broader perioperative pain literature indicating that early central sensitization and psychosocial factors predict persistence beyond the typical three-month surgical recovery window.","Prior coverage emphasized prevalence estimates but omitted the dose-response relationship between pain interference scores and postpartum depression rates (7-46%). Related work in Anesthesiology 2023 on multimodal analgesia trials and a 2024 Lancet Regional Health cohort on pelvic girdle pain demonstrate that women receiving neuraxial opioids plus scheduled NSAIDs had 30% lower chronic pain incidence at six months, suggesting modifiable pathways the current synthesis did not stratify.","Next steps require prospective cohorts with validated functional endpoints and randomization to enhanced recovery bundles versus usual care, measuring both pain trajectories and health-related quality-of-life instruments at one and three years. Without such interventional data, associations cannot distinguish whether pain drives functional decline or whether preexisting mood and sleep disturbance amplify pain reporting."}